OxyContin-Stained Sackler Fortune Too Toxic for This Woke Hedge Fund

Under fire for fueling the opioid crisis, the billionaire family that controls OxyContin maker Purdue Pharma LP has been booted from a large hedge fund, the Wall Street Journal reports. Hildene Capital Dumps Family Behind OxyContin Fortune Last year, Hildene Capital Management, which manages some $10 billion in client assets, notified Sackler family investment entities […]

Continue Reading